Malignant transformation of the colorectal mucosa in inflammatory bowel disease
Author: Sjöqvist, Urban
Date: 2003-03-07
Location: Aulan, Södersjukhuset
Time: 9.00
Department: Institutionen Södersjukhuset / Karolinska Institutet, Stockholm Söder Hospital
View/ Open:
Thesis (747.9Kb)
Abstract
Ulcerative colitis (UC) and Crohn's disease (CD) are disorders of unknown etiology, often referred to as inflammatory bowel diseases (IBD). The increased risk of colorectal cancer (CRC) in patients with longstanding, extensive colonic IBD is an important clinical problem. Colonoscopic surveillance, annually or every second year, with multiple biopsies for histopathological detection of dysplasia, is now used to manage this increased risk at many centers for IBD. Dysplasia is a useful prognostic marker for subsequent cancer development but has limitations including substantial inter- and intra-observer variability among pathologists. Furthermore, concomitant active inflammation makes assessment and interpretation of dysplasia difficult.
There is a need for more accurate and more objective markers for neoplastic transformation of the colorectal mucosa in high-risk individuals. Although long-term treatment with 5-ASA compounds seems to lower the risk of CRC in IBD, no studies using primarily preventive drugs have been performed.
The aims of this thesis were to assess the utility of other markers for malignant transformation of the colorectal mucosa and also to explore any potential chemo-preventive properties of long-term oral therapy with ursodeoxycholic acid in high-risk patients with IBD.
By using monoclonal antibodies, the expression of the proliferative antigens Ki-67 and PCNA was assessed in biopsy specimens with various degrees of epithelial dysplasia and inflammatory changes. Increased staining with MIB-1 and PCNA correlated with increased severity of dysplasia but also with increased inflammation. In the absence of inflammation, immunostaining with these two antibodies may complement dysplasia, especially in the indefinite changes category.
Alkaline sphingomyelinase (SMase) hydrolyses sphingomyelin (SM) generating ceramide which is important in the regulation of cell growth. The activity of alkaline SMase activity is decreased in CRC and premalignant conditions and was also found to be decreased in IBD-patients. There was also an age-dependent decrease of alkaline SMase both in IBD- patients and controls.
Flow cytometric DNA-analyses of biopsy specimen can detect gross chromosomal aberrations and also have the ability to correctly estimate the number of cells in proliferation (S-phase). In normal colorectal mucosa it was found that the S-phase increased linearly with age and decreased from the right colon over the transverse colon to the left colon. The fraction of G2cells increased significantly with increased S-phase fraction. No aneuploidy was detected.
In 324 UC-patients undergoing colonoscopic surveillance, the S-phase of aneuploid samples was significantly increased compared to diploid, but significantly lowered in comparison with sporadic CRC. An increase in S-phase fraction in patients with IBD without active inflammation may be an additional marker for neoplastic potential in the colorectal mucosa.
Ursodeoxycholic acid, a natural bile salt, has been associated with regression of experimentally induced neoplasia in rats. In a two year prospective, double blind randomized pilot study in high-risk IBD-patients, none of the ten patients in the treatment group had progression of dysplasia, while two of the nine patients in the placebo group were refered for colectomy due to progression of dysplasia. UDCA may exert chemo-preventive action(s) in patients with longstanding IBD in the colon, but further studies are needed in order to determine optimal selection of patients, UDCA-dose and treatment time.
There is a need for more accurate and more objective markers for neoplastic transformation of the colorectal mucosa in high-risk individuals. Although long-term treatment with 5-ASA compounds seems to lower the risk of CRC in IBD, no studies using primarily preventive drugs have been performed.
The aims of this thesis were to assess the utility of other markers for malignant transformation of the colorectal mucosa and also to explore any potential chemo-preventive properties of long-term oral therapy with ursodeoxycholic acid in high-risk patients with IBD.
By using monoclonal antibodies, the expression of the proliferative antigens Ki-67 and PCNA was assessed in biopsy specimens with various degrees of epithelial dysplasia and inflammatory changes. Increased staining with MIB-1 and PCNA correlated with increased severity of dysplasia but also with increased inflammation. In the absence of inflammation, immunostaining with these two antibodies may complement dysplasia, especially in the indefinite changes category.
Alkaline sphingomyelinase (SMase) hydrolyses sphingomyelin (SM) generating ceramide which is important in the regulation of cell growth. The activity of alkaline SMase activity is decreased in CRC and premalignant conditions and was also found to be decreased in IBD-patients. There was also an age-dependent decrease of alkaline SMase both in IBD- patients and controls.
Flow cytometric DNA-analyses of biopsy specimen can detect gross chromosomal aberrations and also have the ability to correctly estimate the number of cells in proliferation (S-phase). In normal colorectal mucosa it was found that the S-phase increased linearly with age and decreased from the right colon over the transverse colon to the left colon. The fraction of G2cells increased significantly with increased S-phase fraction. No aneuploidy was detected.
In 324 UC-patients undergoing colonoscopic surveillance, the S-phase of aneuploid samples was significantly increased compared to diploid, but significantly lowered in comparison with sporadic CRC. An increase in S-phase fraction in patients with IBD without active inflammation may be an additional marker for neoplastic potential in the colorectal mucosa.
Ursodeoxycholic acid, a natural bile salt, has been associated with regression of experimentally induced neoplasia in rats. In a two year prospective, double blind randomized pilot study in high-risk IBD-patients, none of the ten patients in the treatment group had progression of dysplasia, while two of the nine patients in the placebo group were refered for colectomy due to progression of dysplasia. UDCA may exert chemo-preventive action(s) in patients with longstanding IBD in the colon, but further studies are needed in order to determine optimal selection of patients, UDCA-dose and treatment time.
List of papers:
I. Sjoqvist U, Ost A, Lofberg R (1999). Increased expression of proliferative Ki-67 nuclear antigen is correlated with dysplastic colorectal epithelium in ulcerative colitis. Int J Colorectal Dis. 14(2): 107-13.
Pubmed
II. Sjoqvist U, Hertervig E, Nilsson A, Duan RD, Ost A, Tribukait B, Lofberg R (2002). Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activity. Inflamm Bowel Dis. 8(4): 258-63.
Pubmed
III. Sjoqvist U, Lofberg R, Ost A, Tribukait B (2002). Age- and site-dependent cell cycle composition of the normal human colonic mucosa. Anticancer Res. 22(6B): 3437-41.
Pubmed
IV. Sjoqvist U, Lofberg R, Torkvist L, Akerlund JE, Wang N, Tribukait B (2003). The significance of DNA-ploidy and S-phase fraction for detection of neoplasia in 324 patients with ulcerative colitis. [Manuscript]
V. Sjoqvist U, Tribukait B, Ost A, Einarsson C, Oxelmark L, Lofberg R (2003). Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy - a prospective, double blind, randomized controlled pilot study. [Submitted]
I. Sjoqvist U, Ost A, Lofberg R (1999). Increased expression of proliferative Ki-67 nuclear antigen is correlated with dysplastic colorectal epithelium in ulcerative colitis. Int J Colorectal Dis. 14(2): 107-13.
Pubmed
II. Sjoqvist U, Hertervig E, Nilsson A, Duan RD, Ost A, Tribukait B, Lofberg R (2002). Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activity. Inflamm Bowel Dis. 8(4): 258-63.
Pubmed
III. Sjoqvist U, Lofberg R, Ost A, Tribukait B (2002). Age- and site-dependent cell cycle composition of the normal human colonic mucosa. Anticancer Res. 22(6B): 3437-41.
Pubmed
IV. Sjoqvist U, Lofberg R, Torkvist L, Akerlund JE, Wang N, Tribukait B (2003). The significance of DNA-ploidy and S-phase fraction for detection of neoplasia in 324 patients with ulcerative colitis. [Manuscript]
V. Sjoqvist U, Tribukait B, Ost A, Einarsson C, Oxelmark L, Lofberg R (2003). Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy - a prospective, double blind, randomized controlled pilot study. [Submitted]
Issue date: 2003-02-14
Rights:
Publication year: 2003
ISBN: 91-7349-415-1
Statistics
Total Visits
Views | |
---|---|
Malignant ...(legacy) | 811 |
Malignant ... | 126 |
Total Visits Per Month
September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | |
---|---|---|---|---|---|---|---|
Malignant ... | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
File Visits
Views | |
---|---|
thesis.pdf(legacy) | 216 |
thesis.pdf | 38 |
thesis.pdf.txt(legacy) | 2 |
Top country views
Views | |
---|---|
United States | 359 |
China | 95 |
Sweden | 76 |
Germany | 62 |
South Korea | 19 |
Iran | 18 |
Russia | 12 |
United Kingdom | 11 |
Denmark | 9 |
Finland | 8 |
Top cities views
Views | |
---|---|
Beijing | 46 |
Sunnyvale | 38 |
Romeo | 36 |
Kiez | 18 |
Seoul | 18 |
Stockholm | 12 |
Nürnberg | 11 |
London | 8 |
Ballerup | 6 |
Dublin | 6 |